Related Experiment Video
Updated: Jun 25, 2025

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
Dipeptidylpeptidase-4-targeted activatable fluorescent probes visualize senescent cells.
Hisamichi Tanaka1,2, Sho Sugawara1, Yoko Tanaka1
1Division of Cellular Senescence, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
Researchers developed novel fluorescent probes that target dipeptidylpeptidase-4 (DPP4) to detect senescent cells. This breakthrough enables in vivo visualization of senescent cells, paving the way for new cancer diagnostics and senotherapy strategies.
Area of Science:
- Biomedical research
- Cancer biology
- Molecular imaging
Background:
- Senescent cells contribute to cancer progression via chronic inflammation and the senescence-associated secretory phenotype (SASP).
- Existing senotherapeutic strategies lack in vivo methods for detecting and evaluating senescent cell accumulation.
Purpose of the Study:
- To develop and validate a technology for the in vivo detection and evaluation of senescent cells.
- To identify effective fluorescent probes for visualizing senescent cells in living organisms.
Main Methods:
- Enzymatic activity-based screening of fluorescent probes.
- Identification of activatable fluorescent probes targeting dipeptidylpeptidase-4 (DPP4).
- In vivo imaging of senescent cells in mouse organs using DPP4-targeted probes.
Main Results:
- Activatable fluorescent probes targeting DPP4 were identified as effective for senescent cell detection.
- These probes demonstrated high selectivity and rapid activation in senescent cells during live imaging.
- Successful visualization of senescent cells in mouse organs was achieved using DPP4-targeted probes.
Conclusions:
- DPP4-targeted fluorescent probes offer a promising tool for in vivo senescent cell detection.
- This technology could lead to noninvasive diagnostic methods for senescent cell accumulation.
- The findings support the potential application of DPP4 prodrugs in senotherapy.
More Related Videos
14:01Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry
Published on: September 13, 2022
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019